NanoHorizons Inc. today announced that it has raised approximately $6.7 million in a second round of funding from Penn Venture Partners, L.P., Life Sciences Greenhouse of Central Pennsylvania, and a number of private investors.
Two early stage cancer therapy companies, Oncologic and Triton BioSystems, have merged to create Aduro BioTech. Aduro, which is privately held, will be headquartered at the former Oncologic facility in Berkeley, California.
EI Company, a leading provider of high-resolution imaging and analysis systems, announced today that it has selected Shimadzu Corporation, developer of analytical measuring and technology systems, as a sales agent in Japan.
Calando Pharmaceuticals doses first patient with CALAA-01, a targeted nanoparticle therapeutic. This represents the first siRNA therapeutic to enter the clinic in oncology and the first targeted delivery of any RNAi product.
BioForce Nanosciences Holdings, Inc., a producer of integrated biological and mechanical systems for life science researchers at the micro and nano scales, today announced that it has signed a distribution agreement with NanoAndMore USA, Inc., the North and South American distribution arm of NanoWorld Holding AG.
Nantero, Inc., a nanotechnology company using carbon nanotubes for the development of next-generation semiconductor devices, has announced collaboration with SVTC Technologies to accelerate the commercialization of nanotube-based electronics products.
mPhase Technologies, Inc, through its wholly owned subsidiary AlwaysReady, Inc., announced that it has completed a short educational animation depicting the technology behind the revolutionary Smart NanoBattery.
As part of its Masdar Initiative, the Abu Dhabi Future Energy Co. is significantly expanding its investment in solar energy by contracting with Applied Materials to purchase three SunFab Thin Film Lines for producing solar modules.